Skip to main content
. 2022 Mar 28;14(7):1709. doi: 10.3390/cancers14071709

Table 2.

Multivariable-adjusted HRs of CCA and HCC.

Variable/Group CCA Incidence a HCC Incidence b p-Value for Heterogeneity
No. of Cases p HR (95% CI) No. of
Cases
p HR (95% CI)
Age, years
Per 10-year older 1388 <0.001 2.59 (2.13–3.14) 2920 <0.001 1.62 (1.42–1.85) <0.001
Sex, men (vs. women) 945 <0.001 1.91 (1.66–2.19) 2407 <0.001 3.77 (3.38–4.20) <0.001
Smoking status
 Never smoker 794 1.00 (Reference) 1424 1.00 (Reference)
 Past smoker 143 0.154 1.15 (0.95–1.36) 347 0.163 1.09 (0.97–1.24) 0.664
 Current smoker, <1 pack/day 318 <0.001 1.31 (1.13–1.52) 863 <0.001 1.35 (1.23–1.49) 0.701
           ≥1 pack/day 84 0.002 1.46 (1.14–1.85) 158 0.116 0.87 (0.73–1.03) 0.001
Alcohol use, g ethanol/day
 None 743 1.00 (Reference) 1387 1.00 (Reference)
 <10 222 0.257 0.91 (0.78–1.07) 542 0.002 0.84 (0.76–0.94) 0.430
 10–39 277 0.032 1.19 (1.01–1.39) 632 0.402 0.96 (0.86–1.06) 0.025
 ≥40 120 <0.001 1.54 (1.25–1.89) 284 <0.001 1.40 (1.22–1.60) 0.460
 Per 140 g ethanol/week increase 1388 <0.001 1.12 (1.06–1.17) 2920 <0.001 1.11 (1.07–1.15) 0.869
Body mass index, kg/m 2
 <18.5 35 0.173 0.79 (0.56–1.11) 73 0.975 1.00 (0.79–1.26) 0.270
 18.5–24.9 847 1.00 (Reference) 1840 1.00 (Reference)
 25–29.9 458 0.157 1.09 (0.97–1.22) 927 0.578 0.98 (0.90–1.06) 0.139
 ≥30 48 0.025 1.40 (1.04–1.88) 80 0.380 1.11 (0.88–1.38) 0.212
 Per 5 kg/m2 increase 1388 0.006 1.13 (1.04–1.23) 2920 0.864 0.99 (0.93–1.06) 0.020
Diabetes status (serum glucose, mg/dL)
 Normoglycemia (<100) 796 1.00 (Reference) 1640 1.00 (Reference)
 IFG (101–125) 341 0.412 1.05 (0.93–1.20) 693 0.010 1.13 (1.03–1.23) 0.417
 Diabetes (≥126 or known diabetes) 251 <0.001 1.36 (1.18–1.57) 587 <0.001 1.83 (1.66–2.01) 0.001
 Per 18 mg/dL increase 1388 0.013 1.05 (1.01–1.09) 2920 <0.001 1.12 (1.10–1.15) 0.002
Alanine aminotransferase (ALT), IU/L
 <20 481 <0.001 0.79 (0.71–0.90) 299 <0.001 0.35 (0.30–0.40) <0.001
 20–39 691 1.00 (Reference) 1029 1.00 (Reference)
 40–59 139 0.164 1.14 (0.95–1.37) 711 <0.001 3.47 (3.15–3.83) <0.001
 60–79 43 0.056 1.35 (0.99–1.84) 372 <0.001 6.09 (5.39–6.88) <0.001
 ≥80 34 0.135 1.30 (0.92–1.84) 509 <0.001 8.63 (7.70–9.66) <0.001
Total cholesterol, mg/dL
 Per 39 mg/dL increase 1388 0.001 0.91 (0.87–0.97) 2920 <0.001 0.55 (0.53–0.57) <0.001
Comorbid liver disease
 Hepatitis B virus infection 14 <0.001 2.71 (1.60–4.59) 287 <0.001 11.80 (10.27–13.57) <0.001
 Hepatitis C virus infection 3 0.369 1.89 (0.47–7.63) 57 <0.001 7.99 (6.11–10.44) 0.047
 Liver cirrhosis 4 0.619 1.29 (0.48–3.45) 255 <0.001 19.38 (16.71–22.47) <0.001
 Alcoholic liver disease 15 0.151 1.45 (0.87–2.43) 81 <0.001 1.79 (1.42–2.24) 0.474
Biliary tract disease
 Cholelithiasis (gallstone disease) 18 0.004 2.94 (1.40–6.17) 13 0.131 1.53 (0.88–2.64) 0.164
 Choledocholithiasis (bile duct stone) 11 <0.001 13.73 (7.58–24.88) 2 0.692 1.32 (0.33–5.30) 0.002

Abbreviations: HR—hazard ratio; 95% CI—95% confidence interval; CCA—cholangiocarcinoma; HCC—hepatocellular carcinoma; IFG—impaired fasting glucose. a Adjustment for age, sex, smoking, alcohol consumption, physical activity, income, BMI, serum glucose, hepatitis B infection, and choledocholithiasis. b Adjustment for age, sex, smoking, alcohol consumption, physical activity, income, BMI, serum glucose, liver cirrhosis, hepatitis B virus, and hepatitis C infection.